NASDAQ: IMVT · Biotechnology
Over the past week, Immunovant (IMVT) saw 10 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 17% bullish but is far apart: X runs 50% bullish while News sits at just 0%. Wall Street is more constructive, with 13 of 17 analysts rating IMVT a buy.
There is little buzz around IMVT this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 76% buy share sits next to a crowd that ranges from News at 0% to X at 50%. No other tracker puts the two side by side.
Across 17 analysts the consensus is a Strong Buy: 13 buy calls against 0 sell, with an average 12-month price target of $48.88.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 59 points above the crowd average of 17%, the professionals are more constructive than retail. The split is inside the crowd: X reads 50% bullish while News sits at 0%, a 50-point spread that single-source trackers miss.
Over the 30-day window, Immunovant (IMVT) buzz held subdued around 27.1 while the price drifted down 18.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.6M shares. Updated Oct 10, 2026. Over the last 7 trading days, IMVT lost 9.5%. Buzz activity in the recent week averaged 16.3 and was variable, swinging between 1.6 and 27.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 5 of the 11 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IMVT and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IMVT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (13 / 4 / 0) |
| Crowd bullish (7d) | 17% |
| Avg price target | $48.88 |
| Most bullish source | X, 50% |
| Most bearish source | News, 0% |
| Sentiment spread | 50 pts |
| Mentions (7d) | 10 |
| Market cap | $6.25B |
| EPS · Beta | -$2.66 · 0.8 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Immunovant (IMVT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 17% bullish across 3 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Immunovant (IMVT) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Immunovant (IMVT), averaging 17% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 50% bullish and News at 0%, a 50-point spread. On the professional side, 13 of 17 analysts rate IMVT a buy.
Of the 17 analysts covering Immunovant (IMVT), 13 rate it a buy, 4 a hold and 0 a sell, for a strong buy consensus. The average price target is $48.88. That puts the street ahead of the crowd, which averages 17% bullish.
Immunovant (IMVT)'s cross-source average is bearish at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. X reads 50% bullish, News reads 0% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Immunovant (IMVT) at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 0% bullish. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 8 mentions (80% of total volume). X contributes 2 mentions. The cross-source average is bearish at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IMVT's sell signal at 93/100 conviction reflects a bearish cross-source average at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The IMVT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key